DRUG AND MEDICAL DEVICE DEVELOPMENT

Small and medium sized therapeutic and medical device companies have the challenge of possessing all the skills and competencies required to successfully develop their product to market. Ventac Partners has extensive skills in the various aspects of project management and commercialization ranging from drug discovery and intellectual property strategy through the phases of clinical development, regulatory requirements, and business development.

Based on decades of experience from big pharma, we serve the pharma industry within certain areas of disease, where Ventac Partners team possesses particular medical and clinical expertise.

Ventac Partners also possess extensive expertise is in the development of medical devices to be introduced to the introduced to the European, United States and Asian markets.

Peter Damsbo, MD
Partner
Ventac Partners team members possess experience in developing therapeutics and medical devices from early stage discovery, through clinical trials and regulatory approvals (including FDA and EMA), to market entry.

Our team structure is flexible and can be adjusted for different situations. In our drug projects we typically operate with one partner acting as the point of contact and overall project manager. We currently serve therapeutic projects within the areas of diabetes and other autoimmune diseases, cancer, neurology and various medical device relevant projects.

Konstantinos Alevizopoulos, PhD,  Partner
Ventac Partners has concrete experience in working with a large number of CRO’s globally. We help our clients designing the experiments needed to advance their project and to pick the best CRO for the job, based on our previous experience.

Henrik Sandvad Rasmussen, MD, PhD, Partner
Ventac Partners possess more than 50 years of hands-on know-how and insight into drug & medical device development and have taken several products to market, interacting with FDA and EMA.